MY132819A - Pharmaceutical compositions containing n-sulphonylindoline derivatives - Google Patents

Pharmaceutical compositions containing n-sulphonylindoline derivatives

Info

Publication number: MY132819A
Authority: MY; Malaysia
Prior art keywords: amphiphilic; sulphonylindoline; nonionic hydrophilic; derivatives; surfactant
Prior art date: 1996-12-05

Application number

MYPI97005848A

Other languages

English (en)

Inventor

Fuller Simon John

Jean-Claude Gautier

Original Assignee

Sanofi Synthelabo

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-12-05

Filing date

1997-12-04

Publication date

2007-10-31

1997-12-04 Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo

2007-10-31 Publication of MY132819A publication Critical patent/MY132819A/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Cardiology (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Dispersion Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)

MYPI97005848A 1996-12-05 1997-12-04 Pharmaceutical compositions containing n-sulphonylindoline derivatives MY132819A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9614957A FR2756736B1 (fr)	1996-12-05	1996-12-05	Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline

Publications (1)

Publication Number	Publication Date
MY132819A true MY132819A (en)	2007-10-31

Family

ID=9498376

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MYPI97005848A MY132819A (en)	1996-12-05	1997-12-04	Pharmaceutical compositions containing n-sulphonylindoline derivatives

Country Status (25)

Country	Link
EP (1)	EP0941090A1 (is)
JP (1)	JP2000507618A (is)
KR (1)	KR20000069308A (is)
CN (1)	CN1239887A (is)
AR (1)	AR009651A1 (is)
AU (1)	AU716575B2 (is)
BR (1)	BR9712406A (is)
CA (1)	CA2273990A1 (is)
CO (1)	CO4910129A1 (is)
DZ (1)	DZ2362A1 (is)
EE (1)	EE9900206A (is)
FR (1)	FR2756736B1 (is)
HU (1)	HUP0001386A3 (is)
ID (1)	ID23373A (is)
IL (1)	IL129936A0 (is)
IS (1)	IS5062A (is)
MY (1)	MY132819A (is)
NO (1)	NO992724L (is)
NZ (1)	NZ335750A (is)
RU (1)	RU2174394C2 (is)
SK (1)	SK75599A3 (is)
TR (1)	TR199901702T2 (is)
WO (1)	WO1998024430A1 (is)
YU (1)	YU23099A (is)
ZA (1)	ZA9710919B (is)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2786486B3 (fr) *	1998-11-16	2000-12-08	Sanofi Sa	Procede de preparation du (2s)-1-[(2r,3s)-5-chloro-3-(2- chlorophenyl)-1-(3,4-dimethoxy benzenesulfonyl)-3-hydroxy- 2,3-dihydro-1h-indole-2-carbonyl]pyrrolidine-2-carboxamide, de ses solvats et/ou hydrates
DE19913692A1 (de) *	1999-03-25	2000-09-28	Basf Ag	Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen
US6437006B1 (en)	1999-09-27	2002-08-20	American Cyanamid Company	Pharmaceutical carrier formulation
CA2359945C (en)	1999-11-12	2011-04-26	Abbott Laboratories	Inhibitors of crystallization in a solid dispersion
US7364752B1 (en)	1999-11-12	2008-04-29	Abbott Laboratories	Solid dispersion pharamaceutical formulations
FR2805992A1 (fr) *	2000-03-08	2001-09-14	Sanofi Synthelabo	Compositions pharmaceutiques orales contenant des derives de n-sulfonylindoline
DE10026698A1 (de)	2000-05-30	2001-12-06	Basf Ag	Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
ITMI20011338A1 (it)	2001-06-26	2002-12-26	Farmatron Ltd	Composizioni farmaceutiche orali a rilascio immediato del principio attivo
US8025899B2 (en)	2003-08-28	2011-09-27	Abbott Laboratories	Solid pharmaceutical dosage form
UA119324C2 (uk) *	2013-04-02	2019-06-10	Теміс Медікер Лімітед	Композиції фармацевтично активних речовин, що містять моноетиловий ефір діетиленгліколю або інші алкільні похідні
KR102139338B1 (ko) *	2013-06-24	2020-07-29	주식회사 엘지생활건강	인돌 화합물을 포함하는 용해도가 개선된 화장료 조성물
KR102139339B1 (ko) *	2013-06-24	2020-07-29	주식회사 엘지생활건강	인돌 화합물을 포함하는 용해도가 개선된 화장료 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3237814A1 (de) *	1982-10-12	1984-04-12	Warner-Lambert Co., 07950 Morris Plains, N.J.	Wasserfreie emulsionen und verwendung derselben
FR2679903B1 (fr) *	1991-08-02	1993-12-03	Elf Sanofi	Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant.

1996
- 1996-12-05 FR FR9614957A patent/FR2756736B1/fr not_active Expired - Fee Related
1997
- 1997-12-03 DZ DZ970212A patent/DZ2362A1/xx active
- 1997-12-04 IL IL12993697A patent/IL129936A0/xx unknown
- 1997-12-04 SK SK755-99A patent/SK75599A3/sk unknown
- 1997-12-04 CO CO97071118A patent/CO4910129A1/es unknown
- 1997-12-04 CN CN97180304A patent/CN1239887A/zh active Pending
- 1997-12-04 BR BR9712406-0A patent/BR9712406A/pt unknown
- 1997-12-04 ID IDW990445D patent/ID23373A/id unknown
- 1997-12-04 JP JP10525294A patent/JP2000507618A/ja active Pending
- 1997-12-04 AU AU53262/98A patent/AU716575B2/en not_active Ceased
- 1997-12-04 NZ NZ335750A patent/NZ335750A/en unknown
- 1997-12-04 ZA ZA9710919A patent/ZA9710919B/xx unknown
- 1997-12-04 KR KR1019997004983A patent/KR20000069308A/ko not_active Ceased
- 1997-12-04 TR TR1999/01702T patent/TR199901702T2/xx unknown
- 1997-12-04 CA CA002273990A patent/CA2273990A1/fr not_active Abandoned
- 1997-12-04 HU HU0001386A patent/HUP0001386A3/hu unknown
- 1997-12-04 AR ARP970105696A patent/AR009651A1/es unknown
- 1997-12-04 EE EEP199900206A patent/EE9900206A/xx unknown
- 1997-12-04 WO PCT/FR1997/002210 patent/WO1998024430A1/fr not_active Ceased
- 1997-12-04 EP EP97950228A patent/EP0941090A1/fr not_active Withdrawn
- 1997-12-04 RU RU99114019/14A patent/RU2174394C2/ru active
- 1997-12-04 MY MYPI97005848A patent/MY132819A/en unknown
1999
- 1999-05-26 YU YU23099A patent/YU23099A/sr unknown
- 1999-06-01 IS IS5062A patent/IS5062A/is unknown
- 1999-06-04 NO NO992724A patent/NO992724L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
NO992724D0 (no)	1999-06-04
RU2174394C2 (ru)	2001-10-10
SK75599A3 (en)	2000-08-14
EP0941090A1 (fr)	1999-09-15
HUP0001386A3 (en)	2002-03-28
FR2756736A1 (fr)	1998-06-12
CO4910129A1 (es)	2000-04-24
AR009651A1 (es)	2000-04-26
EE9900206A (et)	1999-12-15
BR9712406A (pt)	1999-08-31
CA2273990A1 (fr)	1998-06-11
AU716575B2 (en)	2000-03-02
AU5326298A (en)	1998-06-29
WO1998024430A1 (fr)	1998-06-11
FR2756736B1 (fr)	1999-03-05
JP2000507618A (ja)	2000-06-20
YU23099A (en)	1999-11-22
IS5062A (is)	1999-06-01
DZ2362A1 (fr)	2002-12-28
HUP0001386A2 (hu)	2001-04-28
NO992724L (no)	1999-06-04
TR199901702T2 (en)	1999-09-21
IL129936A0 (en)	2000-02-29
ZA9710919B (en)	1999-06-04
KR20000069308A (ko)	2000-11-25
ID23373A (id)	2000-04-20
CN1239887A (zh)	1999-12-29
NZ335750A (en)	2001-06-29

Publication	Publication Date	Title
MY132819A (en)	2007-10-31	Pharmaceutical compositions containing n-sulphonylindoline derivatives
EP1334719A3 (en)	2003-09-24	Pentafluorobenzenesulfonamides and analogs
FI964624A0 (fi)	1996-11-19	Menetelmä duokarmysiinijohdannaisten stabiloimiseksi
SG49049A1 (en)	1998-05-18	5-(-2-Imidazolinylamino) benzimidazole derivatives their preparation and their use as alpha-2 adrenoceptor agonists
PL313821A1 (en)	1996-07-22	Analogues of distamycin a as anticarcinogenic and antiviral agents
CA2129288A1 (en)	1995-02-18	Phosphonooxymethyl Esters of Taxane Derivatives
BR0208794A (pt)	2004-03-09	Composições com baixa espumação/desespumantes contendo compostos alcoxilados de amÈnio quaternário
PL315576A1 (en)	1996-11-12	Analogues of 12,13-isotaxole, their anticarcinogenic application and compositions containing such compounds
CA2108975A1 (en)	1992-10-23	Lavatory Cleansing Blocks
AU698744B2 (en)	1998-11-05	Oil-in-water emulsions
IL163865A0 (en)	2005-12-18	Compositions comprising a non-ionicsurfactant and n-docosanol
MY128392A (en)	2007-01-31	6ALPHA, 9ALPHA-DIFLUORO-17ALPHA-(2-FURANYLCARBOXYL)OXY]-11ß-HYDROXY-16ALPHA-METHYL-3-OXO-ANDROST-1,4,-DIENE-17-CARBOTHIOIC ACID S-FLUOROMETHYL ESTER AS AN ANTI-INFLAMMATORY AGENT
EP0638078A4 (en)	1995-03-22	Avermectin difluoro derivatives.
MX9606565A (es)	1997-03-29	Composiciones blanqueadoras.
AU2881399A (en)	1999-11-23	N1-modified glycopeptides
BG102716A (en)	1999-09-30	Method for the treatment of cardiac insufficiency by means of formulations opposing the endotheline
DK0593520T3 (da)	2000-04-03	Forbindelser med indhold af steroider og deres anvendelse til behandling af glaucom
NO20013499D0 (no)	2001-07-13	Farmasöytisk blanding omfattende en kombinasjon av en profen og andre aktive forbindelser
AU4435093A (en)	1994-03-03	Methods and agents for combating cockroaches
ES2054827T3 (es)	1994-08-16	Uso de alquil fosfatos para la estabilizacion de composiciones tixotropicas.
TH42036A (th)	2000-12-26	สารผสมทางเภสัชกรรมที่ประกอบด้วยอนุพันธ์ของ n-ซัลโฟนิลอินโดลีน
MX9706845A (es)	1997-11-29	Dispersiones de peroxido organico de diacilo solido.
MX9707233A (es)	1997-11-29	Composiciones que comprenden agentes tensioactivos de azucar.